Trial Profile
Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction: A 24-Week Open-Label, Single-Arm Pilot Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- 08 May 2009 Actual number of patients (36) added as reported by ClinicalTrials.gov
- 08 May 2009 Actual end date (1 Apr 2009) as reported by ClinicalTrials.gov.
- 08 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.